Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds ...
People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of ...
Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.
Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...
Most people have heard of stem cells. They are often described as "miracle" cells –ones that can grow into any other type of ...
A team of scientists has mapped the regions surrounding stem cells in planarians—small flatworms that are famous for being able to regrow whole bodies from small fragments—and discovered something ...
Orphan drug designation provides benefits such as tax credits, PDUFA fee waivers, and 7 years of market exclusivity upon approval. FDA designates MNV-201 as an orphan drug for myelodysplastic syndrome ...
More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the blood. Hemodialysis is a precursor to kidney ...
New research based on adults who were cured of HIV after stem cell transplants may offer hope to ultimately have a global impact on HIV care. A total of 10 individuals with HIV have been cured to date ...
"Without batting an eye, he said, 'When do we go?'" Nick Mondek said of his son. When Dr. Nick Mondek learned his cancer had returned this spring, he didn't know that his 10-year-old son Stephen would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results